VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2022 | De-escalation of therapy in early-stage TNBC

Oleg Gluz, MD, Evang. Krankenhaus “”Bethesda”” Klinik, Mönchengladbach, Germany, talks on treatment de-escalation approaches in triple-negative breast cancer (TNBC), highlighting the role of clinical markers, sensitivity to chemotherapy and the immune microenvironment can help guide decision-making in early TNBC. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter